Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Sonrotoclax in Multiple Myeloma: NCT07687004 Clinical Landscape Report 2026
16 September 2026
NCT07687004 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GSM-779690T in Alzheimer Disease: NCT07690228 Clinical Landscape Report 2026
16 September 2026
NCT07690228 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
TNB-928b in Recurrent ovarian cancer: NCT07690189 Clinical Landscape Report 2026
16 September 2026
NCT07690189 clinical landscape for Recurrent ovarian cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Adalimumab in Plaque psoriasis: ISRCTN18260393 Clinical Landscape Report 2026
16 September 2026
ISRCTN18260393 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SSGJ-716 in Dermatitis, Atopic: NCT07693738 Clinical Landscape Report 2026
16 September 2026
NCT07693738 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Menthol in Dermatitis, Atopic: NCT07693400 Clinical Landscape Report 2026
16 September 2026
NCT07693400 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Disitamab Vedotin in HER2-Expressing Non-Muscle Invasive Bladder Neoplasms: NCT07693959 Clinical Landscape Report 2026
16 September 2026
NCT07693959 clinical landscape for HER2-Expressing Non-Muscle Invasive Bladder Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and d…
9 min read
ARC-02 in B-Cell Lymphoma: NCT07691606 Clinical Landscape Report 2026
16 September 2026
NCT07691606 clinical landscape for B-Cell Lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pembrolizumab in Ewing Sarcoma: NCT07695311 Clinical Landscape Report 2026
16 September 2026
NCT07695311 clinical landscape for Ewing Sarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Aldesleukin in Metastatic melanoma: NCT07700121 Clinical Landscape Report 2026
16 September 2026
NCT07700121 clinical landscape for Metastatic melanoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Upadacitinib hemihydrate in Colitis, Ulcerative: ACTRN12626000839303 Clinical Landscape Report 2026
16 September 2026
ACTRN12626000839303 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HRS-8797 in Dermatitis, Atopic: NCT07698756 Clinical Landscape Report 2026
16 September 2026
NCT07698756 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.